Effect of a Single Oral Dose of the PDE Inhibitor Milrinone on Exercise Tolerance of Chronic Heart Failure Patients — CPX in Advanced Heart Failure

1991 ◽  
pp. 111-118
Author(s):  
G. Mager ◽  
R. K. Klocke ◽  
U. J. Winter ◽  
A. Gitt ◽  
G. Rommert ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Oral Dose ◽  
Single Oral Dose ◽  
Exercise Tolerance ◽  
Advanced Heart Failure ◽  
Heart Failure Patients

Muscle electrical stimulation improves neurovascular control and exercise tolerance in hospitalised advanced heart failure patients

2016 ◽  
Vol 23 (15) ◽  
pp. 1599-1608 ◽  
Author(s):  
Raphaela V Groehs ◽  
Ligia M Antunes-Correa ◽  
Thais S Nobre ◽  
Maria-Janieire NN Alves ◽  
Maria Urbana PB Rondon ◽  
...  
Keyword(s):  
Heart Failure ◽  
Electrical Stimulation ◽  
Exercise Tolerance ◽  
Advanced Heart Failure ◽  
Heart Failure Patients

Exercise training in advanced heart failure patients: Discordance between improved exercise tolerance and unchanged NT-proBNP levels

2008 ◽  
Vol 126 (1) ◽  
pp. 114-119 ◽  
Author(s):  
Michael Arad ◽  
Yehuda Adler ◽  
Nira Koren-Morag ◽  
Shy Natanzon ◽  
Ben-Ami Sela ◽  
...  
Keyword(s):  
Heart Failure ◽  
Exercise Training ◽  
Exercise Tolerance ◽  
Advanced Heart Failure ◽  
Heart Failure Patients

Coronary Stress Test as a Predictor of Quality of Life in Chronic Heart Failure Patients

2015 ◽  
Vol 69 (1) ◽  
pp. 26-29
Author(s):  
Borjanka Taneva ◽  
Dejan Ristevski
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Chronic Heart Failure ◽  
Conventional Therapy ◽  
Exercise Tolerance ◽  
Therapy Group ◽  
Beta Blockers ◽  
Control Group ◽  
Heart Failure Patients

Abstract Introduction. Exercise tolerance is one of the life quality parmeters in chronic heart failure patients. The aim of our study was to assess the quality of life of patients with chronic heart failure by estimating their exercise tolerance. Methods. We examined 113 patients with stable chronic heart failure in the period of 18 months. They were divided in two groups, a control group (on conventional therapy of angiotensin-converting enzyme inhibitors and diuretics) and a therapy group (conventional therapy plus beta-blockers). The therapy group was divided into 3 subgroups according to the beta-blocker taken (a Metoprolol Bisoprolol and Carvedilol subgroup). Exercise tolerance was detected by coronary trade-mill stress testing every 6 months (only in patients of NYHA FC II and III), symptoms limited or modified after 6-minutes Bruce test. Results. Our results showed that there was a statistically significant difference between the control group and all the therapy subgroups in NYHA FC, NYHA score and exercise tolerance at the end of the study, but there was no difference among the subgroups. Conclusion. Beta-blockers improve the exercise tolerance as a variable defining quality of life.

Sign in / Sign up

Export Citation Format

Share Document